TOP HEADLINES

Featured Story

  • Pfizer, 23andMe start building 5,000-person lupus database

    Pfizer and 23andMe have begun enrolling people in their lupus study. The partners aim to recruit 5,000 people into the study of the genetics of lupus over the next 12 months, in part by asking existing 23andMe customers to participate.

Foundation Medicine teams with IMS on precision medicine service

Foundation Medicine and IMS Health have teamed up to offer a precision medicine service. The alliance brings together Foundation Medicine's cancer genomics database and IMS' real-world evidence platform, a combination the partners think can enable the effective use of more targeted therapies.

Analyst: R&D time pressures mean clinical trial tech and automation are finally taking off

Biopharma companies may finally be fully embracing the wealth of clinical trial technologies now available. The trend, according to the analyst who observed it, is partly a result of the pressure on R&D teams to hustle drugs to market as quickly as possible while also generating the pharmacoeconomic data payers now demand.

Google to pair its cloud-computing power with Broad's analytic tools

Google has signed up a high-profile collaborator to work on its burgeoning cloud genomics platform. The agreement will see the Broad Institute of MIT and Harvard work with Google to create new tools that pair their respective strengths in data analysis and cloud computing, starting with the offering of GATK as a service.

Google steps up wearables plan with clinical trial-focused wristband

Google has revealed its pitch to establish wearables as a cornerstone of clinical trials. The wristband health tracker is aimed squarely at the clinical trial and healthcare sectors, setting it apart from consumer-focused rivals from Apple and Fitbit.

Eisai strikes extensive multiyear IT outsourcing deal with Accenture

Eisai has become the latest in a long line of companies to look to IT outsourcing for cost savings. The drugmaker has handed responsibility for the maintenance, operation and monitoring of much of its IT infrastructure in Japan and the U.S. to Accenture in a pair of long-term deals.

MORE NEWS

From Our Sister Sites

FierceAnimalHealth

The U.S. Department of Agriculture has amended its rules to allow veterinarians to make vaccines in their offices for individual clients, so long as compounds aren't contracted out to unlicensed manufacturers.

FierceBiotech

A team of collaborators drawn from Harvard, Johnson & Johnson and other groups published results from a preclinical animal study Thursday afternoon that underscores the potential for developing the world's first HIV vaccine.